Effects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPD
Open Access
- 30 September 2010
- journal article
- research article
- Published by Elsevier BV in Respiratory Medicine
- Vol. 104 (9), 1288-1296
- https://doi.org/10.1016/j.rmed.2010.05.017
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Update on the Management of COPDSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2008
- Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: A placebo-controlled trialRespiratory Medicine, 2008
- Effects of formoterol on exercise tolerance in severely disabled patients with COPDRespiratory Medicine, 2007
- Effects of Tiotropium With and Without Formoterol on Airflow Obstruction and Resting Hyperinflation in Patients With COPDSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2006
- Improvements in Symptom-Limited Exercise Performance Over 8 h With Once-Daily Tiotropium in Patients With COPDSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2005
- Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPDEuropean Respiratory Journal, 2005
- Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPDEuropean Respiratory Journal, 2004
- The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPDPulmonary Pharmacology & Therapeutics, 2003
- Long-acting β2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified?Current Opinion in Pharmacology, 2003
- Pharmacological similarities and differences between β2-agonistsRespiratory Medicine, 2001